Valuation check: 6431.TW's profit margin is -40.58%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Kuangli Bio-Tech Holdings , Ltd. (6431.TW) currently reports a profit margin of -40.58% as of September 2026. That compares with -49.92% in the prior-year period — up 18.7% year over year. That is below the sector sector average of 13.4%. Use the charts on this page to explore Kuangli Bio-Tech Holdings , Ltd.'s profit margin history and peer comparisons.
Kuangli Bio-Tech Holdings , Ltd.'s profit margin increased from -49.92% to -40.58% — a 18.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Kuangli Bio-Tech Holdings , Ltd.'s profit margin of -40.58% is lower than the its sector sector average of 13.4%. That is roughly 402.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Kuangli Bio-Tech Holdings , Ltd.'s current -40.58% should be judged against industry norms (sector average: 13.4%) and against 6431.TW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -40.58%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for Kuangli Bio-Tech Holdings , Ltd., and consider following 6431.TW for alerts when major investors trade the stock.